May 9, 2024, 10:46
Kai Rejeski: All that we currently know and understand about CAR-T related cytopenias
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X:
“Check out our new review article in The Lancet Haematology: ‘Immune effector cell-associated hematotoxicity after CAR T-cell therapy: from mechanism to management’.
We summarize all that we currently know and understand about CAR-T related cytopenias.” .
Source: Kai Rejeski/X